首页> 外国专利> RAPID, MASSIVELY PARALLEL SINGLE-CELL DRUG RESPONSE MEASUREMENTS VIA LIVE CELL INTERFEROMETRY

RAPID, MASSIVELY PARALLEL SINGLE-CELL DRUG RESPONSE MEASUREMENTS VIA LIVE CELL INTERFEROMETRY

机译:通过活细胞干涉快速,大量并行的单细胞药物反应测量

摘要

A central question in cancer therapy is how individual cells within a population of tumor cells respond to drugs designed to arrest their growth. However, the absolute growth of cells, their change in physical mass, whether cancerous or physiologic, is difficult to measure directly with traditional techniques. Embodiments of the invention provide live cell interferometry (LCI) for rapid, realtime quantification of cell mass in cells exposed to a changing environment. Overall, LCI provides a conceptual advance for assessing cell populations to identify, monitor, and measure single cell responses, such as to therapeutic drugs.
机译:癌症治疗中的一个核心问题是肿瘤细胞群中的单个细胞如何对旨在阻止其生长的药物产生反应。但是,无论是癌变还是生理变迁,细胞的绝对生长及其物理量的变化都很难用传统技术直接测量。本发明的实施例提供了活细胞干涉测量法(LCI),用于对暴露于变化的环境的细胞中的细胞质量进行快速,实时的定量。总体而言,LCI为评估细胞群体以鉴定,监测和测量单细胞反应(例如对治疗药物的反应)提供了概念上的进步。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号